查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762405

主髂動脈阻塞性疾病治療市場規模、佔有率、產業分析報告：依設備類型、治療方案、最終用途、地區，預測至2025-2034年

Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，預計到2034年，主髂動脈阻塞性疾病治療市場規模將達35.6億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

主髂動脈閉塞性疾病治療市場包括主動脈和髂動脈阻塞的醫療和外科治療，這些阻塞通常由動脈粥狀硬化引起。糖尿病、高血壓和肥胖等慢性疾病的發生率上升，推動了對血管內和開放手術的臨床需求。血管內治療，尤其是血管成形術和支架置入術，因其併發症發生率低、住院時間短、患者預後好等特點，已成為首選的治療方法。

市場成長得益於器械技術的進步，包括藥物洗脫支架、生物可吸收支架和影像引導導航系統，這些技術提高了精準度和長期療效。業內人士正致力於混合血運重建技術，以治療複雜病變和多層閉塞，為最佳化治療方案開闢新途徑。此外，門診血管中心也越來越傾向於進行大量微創手術。隨著早期發現、風險分層和生活方式改變計劃的日益重視，整合照護模式的重要性日益凸顯。

影像、人工智慧和血管機器人技術的融合逐漸改變治療模式，為更個人化、資料驅動的醫療服務鋪路。臨床試驗和上市後監測方面的投入持續為器材的安全性、耐用性和性能提供指標。機會在於擴大醫療資源匱乏人群獲得下一代療法的管道，並改進治療演算法以改善高風險患者的預後。市場正穩步發展，朝著技術含量更高、更注重療效的生態系統邁進，並致力於手術效率、長期通暢率和患者生活品質。

主動脈阻塞性疾病治療市場報告重點

依器械類型劃分，血管內器械領域在2024年佔據最大佔有率，這主要是因為在治療主動脈-髂動脈閉塞性疾病方面，微創手術的趨勢日益明顯。

依最終用途劃分，醫院領域在2024年佔據最大佔有率，這得益於其能夠處理需要多學科團隊、先進影像和手術支援的高風險病例。

2024年，由於先進的血管內治療、強有力的償付制度和早期診斷實踐的廣泛應用，北美主動脈-髂動脈閉塞性疾病治療市場佔據最大佔有率。

由於醫療保健可近性的改善、醫療基礎設施的擴大以及人們對血管疾病的認識的提高，預計亞太地區主髂動脈阻塞性疾病治療市場在預測期內將實現最高的年複合成長率。

全球主要公司包括Abbott、BD、Bentley InnoMed、Biotronik SE &Co KG、Boston Scientific Corporation、Cook、Getinge AB、iVascular、Medtronic、Scitech Medical、Terumo Corporation、W. L. Gore &Associates, Inc.。

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球主髂動脈阻塞性疾病治療市場洞察

  • 市場概況
  • 主髂動脈阻塞性疾病治療市場動態
    • 驅動因素與機會
      • 週邊動脈疾病（PAD）盛行率上升
      • 老化人口成長
    • 限制因素與挑戰
      • 先進治療方案成本高昂
  • PESTEL 因素分析
  • 主髂動脈阻塞性疾病治療市場趨勢
  • 價值鏈分析

第5章 全球主髂動脈阻塞性疾病治療市場（依設備類型）

  • 主要調查結果
  • 簡介
  • 血管內器械
  • 外科器械

第6章 全球主髂動脈阻塞性疾病治療市場（依手術方式）

  • 主要調查結果
  • 簡介
  • 血管內手術
  • 混合手術
  • 開放式手術

第7章 全球主髂動脈阻塞性疾病治療市場（依最終用途）

  • 關鍵調查結果
  • 引言
  • 醫院
  • 門診設施
  • 其他

第8章 全球主髂動脈阻塞性疾病治療市場（依地區）

  • 主要調查結果
  • 引言
    • 2020-2034年主髂動脈阻塞性疾病治療市場評估（依地區）
  • 北美
    • 2020-2034年北美：依設備類型
    • 2020-2034年北美：依手術
    • 2020-2034年北美：依最終用途
    • 美國
    • 加拿大
  • 歐洲
    • 2020-2034年歐洲：依設備類型
    • 2020-2034年歐洲：依手術
    • 2020-2034年歐洲：依最終用途
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 2020-2034年亞太地區：依設備類型
    • 2020-2034年亞太地區：依手術
    • 2020-2034年亞太地區：依最終用途
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區國家
  • 中東和非洲
    • 2020-2034年中東和非洲：依設備類型
    • 2020-2034年中東和非洲：依手術
    • 2020-2034年中東和非洲：依最終用途
    • 沙烏地阿拉伯 RABIA
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 中東和非洲其他地區
  • 拉丁美洲
    • 2020-2034年拉丁美洲：依設備類型
    • 2020-2034年拉丁美洲：依手術
    • 2020-2034年拉丁美洲：依最終用途
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地區

第9章 競爭格局

  • 擴張與收購分析
    • 擴張
    • 收購
  • 合作夥伴/合作/協議/公開

第10章 公司簡介

  • Abbott
  • BD.
  • Bentley InnoMed
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Cook
  • Getinge AB
  • iVascular
  • Medtronic
  • Scitech Medical
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Product Code: PM5750

The aorto-iliac occlusive disease treatment market size is expected to reach USD 3.56 billion by 2034, according to a new study by Polaris Market Research. The report "Aorto-Iliac Occlusive Disease Treatment Market Size, Share, & Industry Analysis Report: By Device Type (Endovascular Devices and Surgical Devices), By Procedure, By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The aorto-iliac occlusive disease treatment market addresses the medical and surgical management of arterial blockages occurring in the aorta and iliac arteries, typically caused by atherosclerosis. The increasing prevalence of chronic conditions such as diabetes, hypertension, and obesity has intensified clinical demand for both endovascular and open surgical interventions. Endovascular procedures, particularly angioplasty and stenting, have become the preferred therapeutic approach due to their lower complication rates, reduced hospital stays, and improved patient outcomes.

Market growth is supported by advancements in device technologies, including drug-eluting stents, bioresorbable scaffolds, and image-guided navigation systems, which enhance precision and long-term efficacy. Industry players are focusing on hybrid revascularization techniques to treat complex lesions and multilevel occlusions, creating new avenues for treatment optimization. There is also a rising trend toward outpatient vascular care centers, where minimally invasive interventions are being performed in high volumes. Increasing emphasis on early detection, risk stratification, and lifestyle modification programs has elevated the importance of integrated care models.

The convergence of diagnostic imaging, artificial intelligence, and vascular robotics is gradually transforming the treatment paradigm, paving the way for more personalized, data-driven interventions. Investments in clinical trials and post-market surveillance studies continue to inform device safety, durability, and performance metrics. Opportunities lie in expanding access to next-generation therapies in underserved populations and refining treatment algorithms to improve outcomes in high-risk patients. The market is steadily evolving into a more technologically enabled, outcome-focused ecosystem that emphasizes procedural efficiency, long-term patency, and patient quality of life.

Aorto-Iliac Occlusive Disease Treatment Market Report Highlights

By device type, in 2024, the endovascular devices segment captured the largest share, primarily driven by the increasing preference for minimally invasive surgery in managing aorto-iliac occlusive disease.

Based on end use, in 2024, the hospitals segment accounted for the largest share, fueled by their capacity to manage high-risk cases requiring multidisciplinary teams, advanced imaging, and surgical backup.

In 2024, the North America aorto-iliac occlusive disease treatment market accounted for the largest share due to the widespread use of advanced endovascular procedures, strong reimbursement frameworks, and early diagnosis practices.

The Asia Pacific aorto-iliac occlusive disease treatment market is projected to register the highest CAGR during the forecast period due to rising healthcare access, expanding medical infrastructure, and increasing awareness of vascular conditions.

A few global key players include Abbott; BD.; Bentley InnoMed; Biotronik SE & Co KG; Boston Scientific Corporation; Cook; Getinge AB; iVascular; Medtronic; Scitech Medical; Terumo Corporation; W. L. Gore & Associates, Inc.; and ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Polaris Market Research has segmented the aorto-iliac occlusive disease treatment market on the basis of device type, procedure, end use, and region:

By Device Type Outlook (Revenue, USD Billion, 2020-2034)

Endovascular Devices

Balloon Angioplasty Devices

Atherectomy Systems

Stents

Surgical Devices

By Procedure Outlook (Revenue, USD Billion, 2020-2034)

Endovascular Procedures

Hybrid Procedures

Open Surgical Procedures

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Outpatient Facilities

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Aorto-Iliac Occlusive Disease Treatment Market Insights

  • 4.1. Aorto-Iliac Occlusive Disease Treatment Market - Market Snapshot
  • 4.2. Aorto-Iliac Occlusive Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Peripheral Arterial Disease (PAD)
      • 4.2.1.2. Growing Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Advanced Treatments
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Aorto-Iliac Occlusive Disease Treatment Market Trends
  • 4.6. Value Chain Analysis

5. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • 5.3. Endovascular Devices
    • 5.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Devices, by Region, 2020-2034 (USD Billion)
  • 5.4. Surgical Devices
    • 5.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Surgical Devices, by Region, 2020-2034 (USD Billion)

6. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • 6.3. Endovascular Procedures
    • 6.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Endovascular Procedures, by Region, 2020-2034 (USD Billion)
  • 6.4. Hybrid Procedures
    • 6.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hybrid Procedures, by Region, 2020-2034 (USD Billion)
  • 6.5. Open Surgical Procedures
    • 6.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Open Surgical Procedures, by Region, 2020-2034 (USD Billion)

7. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Outpatient Facilities
    • 7.4.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Outpatient Facilities, by Region, 2020-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Aorto-Iliac Occlusive Disease Treatment Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Aorto-Iliac Occlusive Disease Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Aorto-Iliac Occlusive Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Aorto-Iliac Occlusive Disease Treatment Market - North America
    • 8.3.1. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.3.3. North America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Aorto-Iliac Occlusive Disease Treatment Market - U.S.
      • 8.3.4.1. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Aorto-Iliac Occlusive Disease Treatment Market - Canada
      • 8.3.5.1. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Aorto-Iliac Occlusive Disease Treatment Market - Europe
    • 8.4.1. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Aorto-Iliac Occlusive Disease Treatment Market - UK
      • 8.4.4.1. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Aorto-Iliac Occlusive Disease Treatment Market - France
      • 8.4.5.1. France: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Aorto-Iliac Occlusive Disease Treatment Market - Germany
      • 8.4.6.1. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Aorto-Iliac Occlusive Disease Treatment Market - Italy
      • 8.4.7.1. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Aorto-Iliac Occlusive Disease Treatment Market - Spain
      • 8.4.8.1. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Aorto-Iliac Occlusive Disease Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Aorto-Iliac Occlusive Disease Treatment Market - Russia
      • 8.4.10.1. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Aorto-Iliac Occlusive Disease Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Aorto-Iliac Occlusive Disease Treatment Market - China
      • 8.5.4.1. China: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Aorto-Iliac Occlusive Disease Treatment Market - India
      • 8.5.5.1. India: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Aorto-Iliac Occlusive Disease Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Aorto-Iliac Occlusive Disease Treatment Market - Japan
      • 8.5.7.1. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Aorto-Iliac Occlusive Disease Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Aorto-Iliac Occlusive Disease Treatment Market - South Korea
      • 8.5.9.1. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Aorto-Iliac Occlusive Disease Treatment Market - Australia
      • 8.5.10.1. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Aorto-Iliac Occlusive Disease Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Aorto-Iliac Occlusive Disease Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Aorto-Iliac Occlusive Disease Treatment Market - UAE
      • 8.6.5.1. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Aorto-Iliac Occlusive Disease Treatment Market - Israel
      • 8.6.6.1. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Aorto-Iliac Occlusive Disease Treatment Market - South Africa
      • 8.6.7.1. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Aorto-Iliac Occlusive Disease Treatment Market - Latin America
    • 8.7.1. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Aorto-Iliac Occlusive Disease Treatment Market - Mexico
      • 8.7.4.1. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Aorto-Iliac Occlusive Disease Treatment Market - Brazil
      • 8.7.5.1. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Aorto-Iliac Occlusive Disease Treatment Market - Argentina
      • 8.7.6.1. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Aorto-Iliac Occlusive Disease Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BD.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bentley InnoMed
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Biotronik SE & Co KG
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Boston Scientific Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Cook
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Getinge AB
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. iVascular
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Medtronic
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Scitech Medical
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Terumo Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. W. L. Gore & Associates, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development

List of Tables:

  • Table 1 Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 2 Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 3 Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 5 North America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 6 North America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 9 U.S.: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 12 Canada: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 15 Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 17 UK: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 18 UK: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 20 France: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 21 France: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 24 Germany: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 27 Italy: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 30 Spain: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 36 Russia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 44 China: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 45 China: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 47 India: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 48 India: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 54 Japan: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 60 South Korea: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 63 Australia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 75 UAE: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 78 Israel: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 81 South Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 87 Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 90 Mexico: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 93 Brazil: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 96 Argentina: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Aorto-Iliac Occlusive Disease Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Device Type
  • Figure 7. Global Aorto-Iliac Occlusive Disease Treatment Market, by Device Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Procedure
  • Figure 9. Global Aorto-Iliac Occlusive Disease Treatment Market, by Procedure, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Aorto-Iliac Occlusive Disease Treatment Market, by End Use, 2024 & 2034 (USD Billion)